JP2021511327A5 - - Google Patents

Info

Publication number
JP2021511327A5
JP2021511327A5 JP2020539797A JP2020539797A JP2021511327A5 JP 2021511327 A5 JP2021511327 A5 JP 2021511327A5 JP 2020539797 A JP2020539797 A JP 2020539797A JP 2020539797 A JP2020539797 A JP 2020539797A JP 2021511327 A5 JP2021511327 A5 JP 2021511327A5
Authority
JP
Japan
Prior art keywords
dihydro
quinazolin
piperidine
fluoro
methylphenyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2020539797A
Other languages
English (en)
Japanese (ja)
Other versions
JP7281470B2 (ja
JP2021511327A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2019/051245 external-priority patent/WO2019141808A1/en
Publication of JP2021511327A publication Critical patent/JP2021511327A/ja
Publication of JP2021511327A5 publication Critical patent/JP2021511327A5/ja
Application granted granted Critical
Publication of JP7281470B2 publication Critical patent/JP7281470B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2020539797A 2018-01-19 2019-01-18 C5a受容体調節剤 Active JP7281470B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP2018051283 2018-01-19
EPPCT/EP2018/051283 2018-01-19
PCT/EP2019/051245 WO2019141808A1 (en) 2018-01-19 2019-01-18 C5a receptor modulators

Publications (3)

Publication Number Publication Date
JP2021511327A JP2021511327A (ja) 2021-05-06
JP2021511327A5 true JP2021511327A5 (cg-RX-API-DMAC7.html) 2022-01-21
JP7281470B2 JP7281470B2 (ja) 2023-05-25

Family

ID=65023915

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2020539797A Active JP7281470B2 (ja) 2018-01-19 2019-01-18 C5a受容体調節剤

Country Status (6)

Country Link
US (1) US11685729B2 (cg-RX-API-DMAC7.html)
EP (1) EP3740477A1 (cg-RX-API-DMAC7.html)
JP (1) JP7281470B2 (cg-RX-API-DMAC7.html)
CN (1) CN111683937A (cg-RX-API-DMAC7.html)
CA (1) CA3087784A1 (cg-RX-API-DMAC7.html)
WO (1) WO2019141808A1 (cg-RX-API-DMAC7.html)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA124694C2 (uk) 2018-01-10 2021-10-27 Ідорсія Фармасьютікалз Лтд 2,4,6,7-ТЕТРАГІДРОПІРАЗОЛО[4,3-d]ПІРИМІДИН-5-ОНОВІ ПОХІДНІ ТА СПОРІДНЕНІ СПОЛУКИ ЯК МОДУЛЯТОРИ РЕЦЕПТОРА C5A ДЛЯ ЛІКУВАННЯ ВАСКУЛІТУ ТА ЗАПАЛЬНИХ ЗАХВОРЮВАНЬ
WO2019141803A1 (en) 2018-01-19 2019-07-25 Idorsia Pharmaceuticals Ltd C5a receptor modulators
US11685729B2 (en) 2018-01-19 2023-06-27 Idorsia Pharmaceuticals Ltd. C5a receptor modulators

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2118117A1 (en) 1993-02-18 1994-08-19 Shigeki Fujiwara Adenosine uptake inhibitor
KR100607634B1 (ko) 1998-10-16 2006-08-02 다이닛본 스미토모 세이야꾸 가부시끼가이샤 퀴나졸리논 유도체
PL347432A1 (en) 1998-10-23 2002-04-08 Hoffmann La Roche Bicyclic nitrogen heterocycles
JO2355B1 (en) 2003-04-15 2006-12-12 ميرك شارب اند دوم كوربوريشن Hereditary calcitonin polypeptide receptor antagonists
US7476665B2 (en) 2003-06-26 2009-01-13 Merck & Co., Inc. Benzodiazepine CGRP receptor antagonists
WO2005019188A1 (ja) 2003-08-22 2005-03-03 Takeda Pharmaceutical Company Limited 縮合ピリミジン誘導体およびその用途
JP2007515458A (ja) 2003-12-23 2007-06-14 テイボテク・フアーマシユーチカルズ・リミテツド Hivプロテアーゼ阻害剤の自己ミクロ乳化性薬剤送達システム
US20070292421A1 (en) * 2005-07-28 2007-12-20 Feinberg Bruce B Method for treating preeclampsia
WO2007028789A1 (en) 2005-09-07 2007-03-15 Istituto Di Ricerche Di Biologia Molecolare P. Angeletti Spa Quinazoline derivatives as antiviral agents
US7834000B2 (en) 2006-06-13 2010-11-16 Vertex Pharmaceuticals Incorporated CGRP receptor antagonists
EP2027106A2 (en) 2006-06-13 2009-02-25 Vertex Pharmaceuticals Incorporated Cgrp receptor antagonists
CA2656507C (en) 2006-07-17 2012-03-20 Amgen Inc. Quinazoline and pyridopyrimidine derivatives as p38 kinase inhibitors
SA08280783B1 (ar) 2007-01-11 2011-04-24 استرازينيكا ايه بي مشتقات بيريدوبيريميدين كمثبطات pde4
DK2585064T3 (en) * 2010-06-24 2017-07-24 Chemocentryx Inc C5aR antagonists
US20120143725A1 (en) 2010-12-02 2012-06-07 Vinimaya Inc. Methods and systems for influencing search and shopping decisions in electronic procurement
GB201106814D0 (en) 2011-04-21 2011-06-01 Astex Therapeutics Ltd New compounds
MX2016002544A (es) 2013-09-04 2016-06-17 Squibb Bristol Myers Co Compuestos utiles como inmunomoduladores.
RS57508B1 (sr) 2013-09-06 2018-10-31 Aurigene Discovery Tech Ltd 1,2,4-derivati oksadiazola kao imunomodulatori
WO2015044900A1 (en) 2013-09-27 2015-04-02 Aurigene Discovery Technologies Limited Therapeutic immunomodulating compounds
CN114984016A (zh) * 2015-03-13 2022-09-02 雷斯韦洛吉克斯公司 用于治疗补体相关疾病之组合物及治疗方法
UA124694C2 (uk) 2018-01-10 2021-10-27 Ідорсія Фармасьютікалз Лтд 2,4,6,7-ТЕТРАГІДРОПІРАЗОЛО[4,3-d]ПІРИМІДИН-5-ОНОВІ ПОХІДНІ ТА СПОРІДНЕНІ СПОЛУКИ ЯК МОДУЛЯТОРИ РЕЦЕПТОРА C5A ДЛЯ ЛІКУВАННЯ ВАСКУЛІТУ ТА ЗАПАЛЬНИХ ЗАХВОРЮВАНЬ
WO2019141803A1 (en) 2018-01-19 2019-07-25 Idorsia Pharmaceuticals Ltd C5a receptor modulators
US11685729B2 (en) 2018-01-19 2023-06-27 Idorsia Pharmaceuticals Ltd. C5a receptor modulators

Similar Documents

Publication Publication Date Title
RU2481333C2 (ru) Производные 1,1,1-трифтор-2-гидрокси-3-фенилпропана
JP2005531609A5 (cg-RX-API-DMAC7.html)
JP2021511324A5 (cg-RX-API-DMAC7.html)
JP2010519204A5 (cg-RX-API-DMAC7.html)
JP2018535999A5 (cg-RX-API-DMAC7.html)
IL258577A (en) 2,4-dihydroxy-nicotinamides as apj agonists
US9708308B2 (en) Factor IXa inhibitors
JP2019518036A5 (cg-RX-API-DMAC7.html)
JP2013540119A5 (cg-RX-API-DMAC7.html)
JP2013545744A5 (cg-RX-API-DMAC7.html)
JP2003503386A (ja) 1−(芳香族またはヘテロ芳香族置換)−3−(ヘテロ芳香族置換)−1,3−プロパンジオン類およびそれの使用
JP2014531465A5 (cg-RX-API-DMAC7.html)
JP2018530591A5 (cg-RX-API-DMAC7.html)
JP2017535561A5 (cg-RX-API-DMAC7.html)
JP2020532551A5 (cg-RX-API-DMAC7.html)
JP2019509319A5 (cg-RX-API-DMAC7.html)
JP2015164972A5 (cg-RX-API-DMAC7.html)
JP2015526452A5 (cg-RX-API-DMAC7.html)
JP2018508553A5 (cg-RX-API-DMAC7.html)
JP2020520925A5 (cg-RX-API-DMAC7.html)
JP2006528147A5 (cg-RX-API-DMAC7.html)
US9695198B2 (en) Factor IXa inhibitors
JP2020520388A5 (cg-RX-API-DMAC7.html)
JP7224674B2 (ja) フェニルイミダゾール化合物
RU2015138961A (ru) Производные дигидрохинолин-2-она для применения в качестве ингибиторов альдостеронсинтазы